Latest News for: autoimmune
Edit
Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
US News 17 Jun 2026
By Dennis Thompson HealthDay ReporterWEDNESDAY, June 17, 2026 (HealthDay News) — People with an autoimmune disease and obesity might lower their... .
Edit
Can stress trigger autoimmune disease? Doctor explains how it can impact your physiological functions and ...
Hindustan Times 16 Jun 2026
Edit
Venus Williams was diagnosed with Sjögren’s syndrome, an autoimmune disease so exhausting she could barely ...
SpaceDaily 14 Jun 2026
She had been diagnosed with Sjögren’s syndrome, an autoimmune disease that attacks the body’s moisture-producing glands and leaves many patients too drained to get out of bed.
Edit
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at ...
Nasdaq Globe Newswire 12 Jun 2026
— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile — ... .
Edit
The Eagle-Tribune
12 Jun 2026
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic
— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile — ... .
Edit
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as ...
Nasdaq Globe Newswire 12 Jun 2026
.
Edit
The Eagle-Tribune
12 Jun 2026
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune
Edit
The Elkin Tribune
12 Jun 2026
Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc.
Edit
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress (Form 6-K) (HUTCHMED (China) Ltd)
Public Technologies 12 Jun 2026
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress ... in patients with warm autoimmune hemolytic anemia in China.
Edit
IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies
PR Newswire 11 Jun 2026
FDA Fast Track designation in HDFN and warm autoimmune hemolytic anemia (wAIHA) in July 2019, gMG in December 2021, FNAIT in March 2024, Sjögren's disease (SjD) in March 2025, and systemic lupus erythematosus (SLE) in January 2026 U.S.
Edit
DWP confirms full list of 10 autoimmune diseases that qualify for �114 weekly payment
Manchester Evening News 10 Jun 2026
Edit
Lincoln Times-News
10 Jun 2026
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
... autoimmune diseases, solid tumors and hematological malignancies .
Edit
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases (Form 8-K) (Cullinan Therapeutics Inc)
Public Technologies 10 Jun 2026
Edit
Floyd County Chronicle
09 Jun 2026
A revolutionary cancer treatment could transform autoimmune disease
Edit
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases (Form 8-K) (Cartesian Therapeutics Inc)
Public Technologies 09 Jun 2026
) Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases ... in autoimmune diseases.
- 1
- 2
- Next page »